Tag: Insilico Medicine

• Chemistry42 – AI-based drug discovery platform

  Researchers from Insilico Medicine have published a paper in the Journal of Chemical Information and Modeling on the use of its AI platform, Chemistry42, for designing novel drugs for diseases. Launched in 2020, the platform includes 42 generative algorithms, customizable reward functions, and 3D physics-based modules to dynamically assess and optimize the structures. The company…

  Sreeram Penna

  February 7, 2023